Sex differences in metabolic regulation and diabetes susceptibility.

Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, Gourdy P. · 2020

Read Sex differences in metabolic regulation and diabetes susceptibility. by Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, Gourdy P. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6997275.txt.

Introduction

Tramunt and co-authors review why men and women differ in metabolic control and diabetes risk. Their review appeared in Diabetologia. Diabetes is more common in men than women in most of the world, above all in middle age. Animal models show the same pattern.

Many parts of energy balance and glucose handling run differently by sex. In their fertile years, women store fuel in safer places, under the skin rather than around organs. Their insulin sensitivity runs higher, and their insulin output and gut hormone responses are stronger. Those advantages fade as glucose control fails. Protective effects of oestrogens, acting through a main receptor in brain, liver, muscle, fat, and pancreas, explain part of the gap. Sex chromosomes and early-life programming need more study, the authors say.

Catalog record

CREATORTramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, Gourdy P.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6997275

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Sex differences in metabolic regulation and diabetes susceptibility By Blandine Tramunt, Sarra Smati, Naia Grandgeorge, Françoise Lenfant, Jean-François Arnal, Alexandra Montagner, Pierre Gourdy Published in: Diabetologia DOI: 10.1007/s00125-019-05040-3 ABSTRACT Abstract Gender and biological sex impact the pathogenesis of numerous diseases, including metabolic disorders such as diabetes. In most parts of the world, diabetes is more prevalent in men than in women, especially in middle-aged populations. In line with this, considering almost all animal models, males are more likely to develop obesity, insulin resistance and hyperglycaemia than females in response to nutritional challenges. As summarised in this review, it is now obvious that many aspects of energy balance and glucose metabolism are regulated differently in males and females and influence their predisposition to type 2 diabetes. During their reproductive life, women exhibit specificities in energy partitioning as compared with men, with carbohydrate and lipid utilisation as fuel sources that favour energy storage in subcutaneous adipose tissues and preserve them from visceral and ectopic fat accumulation. Insulin sensitivity is higher in women, who are also characterised by higher capacities for insulin secretion and incretin responses than men; although, these sex advantages all disappear when glucose tolerance deteriorates towards diabetes. Clinical and experimental observations evidence the protective actions of endogenous oestrogens, mainly through oestrogen receptor α activation in various tissues, including the brain, the liver, skeletal muscle, adipose tissue and pancreatic beta cells. However, beside sex steroids, underlying mechanisms need to be further investigated, especially the role of sex chromosomes, fetal/neonatal programming and epigenetic modifications. On the path to precision medicine, further deciphering sex-specific traits in energy balance and glucose homeostasis is indeed a priority topic to optimise individual approaches in type 2 diabetes prevention and treatment. Electronic supplementary material The online version of this article (10.1007/s00125-019-05040-3) contains a slideset of the figures for download, which is available to authorised users. Keywords: Diabetes, Energy balance, Glucose metabolism, Oestrogens, Review, Sex differences INTRODUCTION In the last few years, addressing gender and sex differences has emerged as a priority topic in several medical areas, including metabolic diseases [1]. While gender mainly refers to the socially constructed identities of individuals, sex dimorphism relies on the fundamental biological disparities that differently influence physiological or pathophysiological processes in males and females. Although not fully understood, underlying mechanisms largely involve sex steroid hormones and sex chromosomes but also include sex specificities in fetal/neonatal programming and epigenetic modifications. Recent guidelines, thus, emphasise the need to consider such sex differences during preclinical (cellular and animal models) to clinical research efforts, avoiding the traditional male predominance when using these approaches [2]. It is now obvious that sex has a significant impact on the pathogenesis of metabolic disorders, such as type 2 diabetes. The first dimorphic aspect concerns diabetes prevalence, with a male predominance reported in humans and also in most animal models, with females being generally protected from diet-induced metabolic disorders [3]. Therefore, the present review aims to discuss how sex differences in energy balance and metabolic homeostasis influence susceptibility to diabetes, with a specific focus on the protective actions of endogenous oestrogens. DIABETES IS MORE PREVALENT IN MEN: EPIDEMIOLOGICAL EVIDENCE Except in some parts of the world, such as the Middle East and North Africa, diabetes is more prevalent in men than in women, especially in middle-aged populations. Analysing 751 population-based studies (4.4 million adults from 146 countries), the NCD Risk Factor Collaboration first showed that age-standardised prevalence rates more markedly increased in men (4% to 9%) than in women (5% to 8%) between 1980 and 2014, despite some substantial disparities across geographical areas [4]. Similarly, the US National Health and Nutrition Examination Survey recently reported a higher prevalence of diabetes among men compared with women (13% vs 11% for the 2013–2016 period, in adults aged 20–79 years) [5]. The last global estimates published by the International Diabetes Federation also indicate sex differences in worldwide diabetes prevalence in adult populations (9.1% in men vs 8.4% in women), suggesting that about 12.3 million more men than women worldwide were living with diabetes in 2017. The peak in diabetes prevalence occurs earlier in men (65–69 years of age) than in women (70–79 years of age) and male predominance is, therefore, specifically observed in middle-aged populations (35–69 years of age) [6]. Studies offering systematic screening procedures in large populations confirmed a male predominance when diagnosis of diabetes was based on fasting plasma glucose (FPG) and/or HbA1c measurements, but not when considering 2 h plasma glucose after an OGTT (2hPG-OGTT). Among the 7680 men and 9251 women included in the European Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe (DECODE) study, undiagnosed diabetes and impaired fasting glucose, both defined by isolated FPG, were more prevalent in men in the 30–69 years age range. However, the prevalence of impaired glucose tolerance, was higher in women in all age groups [7]. In 13,016 inhabitants (aged 30–60 years) of the Copenhagen county (Denmark) who participated in the Inter99 study, diagnosis of dysglycaemia was reported in 49.6% (95% CI 43.4%, 55.6%) of men and 34.6% (95% CI 28.6%, 41.0%) of women by the age of 60 years. The risk of diabetes (OR 1.7 [95% CI 1.3, 2.1]) and impaired fasting glucose (OR 3.0 [95% CI 2.4, 3.7]), but not of impaired glucose tolerance (OR 1.0 [95% CI 0.9, 1.2]), appeared to be higher in men than in women [8]. In individuals with normal glucose tolerance, women generally exhibit lower FPG and HbA1c levels but increased 2hPG-OGTT levels, as compared with men [9, 10]. However, these differences could be the consequence of challenging all individuals with the same amount of glucose, regardless of sex-dependent characteristics, such as body size, muscle mass or physical fitness [9], but they could also be owing to delayed gut glucose absorption in women as compared with men [11]. These later observations perfectly illustrate the need for considering both sexes, as well as their phenotypic and biological specificities, in all studies devoted to metabolic regulation. A CRITICAL ROLE FOR SEX STEROID HORMONES IN DIABETES SUSCEPTIBILITY Both clinical and experimental studies indicate that post-pubertal sex steroid hormones largely contribute to sex differences in diabetes susceptibility. The protective role of endogenous oestrogens in women is evidenced by the deleterious impact of the menopause on body composition and glucose homeostasis, leading to an increased incidence of metabolic disorders vs premenopausal women [12]. Early menopause and premature ovarian insufficiency are associated with an increased risk of type 2 diabetes as compared with premenopausal women, while a 21–35% reduction in diabetes incidence has been reported in menopausal women receiving oestrogen-based hormonal therapy vs placebo [13–15]. Further demonstrating the contribution of the oestrogen pathway to diabetes susceptibility in humans, rare loss-of-function mutations in the gene encoding either aromatase (the enzyme that converts androgens into oestrogens) or oestrogen receptor α (ERα) result in dysmetabolic phenotypes in individuals of both sexes [16]. Similarly, deletion of aromatase or ERα in transgenic mice also leads to obesity, insulin resistance and impaired glucose tolerance [17, 18]. Moreover, in all animal models, oestrogen-associated protection of females from high-fat-diet (HFD)-induced obesity and hyperglycaemia is totally abolished by bilateral ovariectomy, but restored by oestrogen administration [18, 19]. Androgens are also associated with metabolic risks, but mainly in pathophysiological situations

Read the complete text